Male contraceptive proves effective at preventing pregnancy amongst monkeys

Treating male monkeys with the contraceptive Vasalgel has proved effective at preventing conception amongst rhesus monkeys, reports the California National Primate Research Center.

illustration human sperm

The report is based on findings from a study that involved sixteen rhesus monkeys that were treated with the contraceptive before being returned to outdoor group housing where female monkeys with successful reproductive histories were also living.

Contraceptive options amongst males have not changed for over a century and the demand for methods other than condom use, withdrawal and vasectomy is growing. Although scientists have discovered new targets, no new products have yet reached the market.

As reported in Basic and Clinical Andrology, Catherine A. VandeVoort and colleagues from the research center administered intravas Vasalgel injections to sixteen sexually mature, male rhesus monkeys . Each male was then returned to outdoor housing, where three to nine females were also housed. All of the females were intact and had histories of successful reproduction. The male monkeys were monitored over at least one breeding season and seven of the 16 were housed with the females on an almost continual basis over two years.

“The purpose of the current study was to put Vasalgel to the ultimate test--preventing pregnancy, not just eliminating sperm--in larger animals more anatomically similar to humans, before human use,” states the report.

The researchers found that none of the females in the group conceived over the two year period.

Complications were minor and included one case of a sperm granuloma developing due to incorrect placement of Vasalgel in the vas deferens.

“Intravas injection of Vasalgel in sexually mature adult male rhesus monkeys was effective in preventing conception in a free-living, group environment,” write VandeVoort and team… “Complications were few and similar to those associated with traditional vasectomy.”

The authors say that now the efficacy of Vasalgel has been proven in monkeys and previously rabbits, researchers are now preparing to test the contraceptive in human trials. The first study will test the contraceptive’s efficacy and subsequent studies will assess the possibility of reversal and restoring sperm flow.

An organization called the Parsemus Foundation (Berkeley, California) aims for Vasalgel to become available and affordable to all men globally via a tiered international pricing structure.

Sally Robertson

Written by

Sally Robertson

Sally has a Bachelor's Degree in Biomedical Sciences (B.Sc.). She is a specialist in reviewing and summarising the latest findings across all areas of medicine covered in major, high-impact, world-leading international medical journals, international press conferences and bulletins from governmental agencies and regulatory bodies. At News-Medical, Sally generates daily news features, life science articles and interview coverage.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 19). Male contraceptive proves effective at preventing pregnancy amongst monkeys. News-Medical. Retrieved on September 25, 2020 from

  • MLA

    Robertson, Sally. "Male contraceptive proves effective at preventing pregnancy amongst monkeys". News-Medical. 25 September 2020. <>.

  • Chicago

    Robertson, Sally. "Male contraceptive proves effective at preventing pregnancy amongst monkeys". News-Medical. (accessed September 25, 2020).

  • Harvard

    Robertson, Sally. 2019. Male contraceptive proves effective at preventing pregnancy amongst monkeys. News-Medical, viewed 25 September 2020,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Scientists discover possible biomarkers for detecting opioid use disorder during pregnancy